Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5'-S-ethyl-5'-thioadenosine is a synthetic thionucleoside analog of adenosine in which the hydroxy group at the 5' position of ribose is replaced by an ethylsulfanyl (ethylthio) group. It belongs to the class of organic compounds known as 5'-deoxy-5'-thionucleosides. This compound has been reported as a metabolite and studied in protozoan parasites such as Trypanosoma brucei. Its biological activity is related to its structural similarity to adenosine and methylthioadenosine; however, specific pharmacological mechanisms or clinical uses have not been established. It is considered an experimental small molecule with no approved indications[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5'-S-ethyl-5'-thioadenosine.